Titan Pharmaceuticals' IPO

Titan Pharmaceuticals raised a round of funding on October 10, 2005. Investors include Public.

Titan Pharmaceuticals, Inc. (AMEX: TTP) is focused on the late-stage development and commercialization of innovative treatments for central nervous system disorders including schizophrenia, opioid add…

Articles about Titan Pharmaceuticals' IPO: